Literature DB >> 20677939

Paucity of initial cerebrospinal fluid inflammation in cryptococcal meningitis is associated with subsequent immune reconstitution inflammatory syndrome.

David R Boulware1, Shulamith C Bonham, David B Meya, Darin L Wiesner, Gregory S Park, Andrew Kambugu, Edward N Janoff, Paul R Bohjanen.   

Abstract

BACKGROUND: Cryptococcal meningitis (CM)-related immune reconstitution inflammatory syndrome (IRIS) complicates antiretroviral therapy (ART) in 20%-40% of ART-naive persons with AIDS and prior CM. Pathogenesis is unknown.
METHODS: We compared initial cerebrospinal fluid (CSF) cultures, inflammatory markers, and cytokine profiles in ART-naive patients with AIDS who did or did not subsequently develop IRIS after starting ART. We also compared results obtained at IRIS events or CM relapse.
RESULTS: Of 85 subjects with CM, 33 (39%) developed CM-related IRIS and 5 (6%) developed culture-positive CM relapse. At CM diagnosis, subjects subsequently developing IRIS had less inflammation, with decreased CSF leukocytes, protein, interferon-gamma, interleukin-6, interleukin-8, and tumor necrosis factor-alpha, compared with subjects not developing IRIS (P<.05, for each). Initial CSF white blood cell counts < or =25 cells/microL and protein levels < or =50 mg/dL were associated with development of IRIS (odds ratio, 7.2 [95% confidence interval, 2.7-18.7]; P<.001). Compared with baseline levels, we identified CSF elevations of interferon-gamma, tumor necrosis factor-alpha, granulocyte colony-stimulating factor, vascular-endothelial growth factor, and eotaxin (CCL11) (P<.05, for each) at the time of IRIS but minimal inflammatory changes in those with CM relapse.
CONCLUSIONS: Patients who subsequently develop CM-related IRIS exhibit less initial CSF inflammation at the time of CM diagnosis, compared with those who do not develop IRIS. The inflammatory CSF cytokine profiles observed at time of IRIS can distinguish IRIS from CM relapse.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20677939      PMCID: PMC2924457          DOI: 10.1086/655785

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  43 in total

1.  Clinical utility of monitoring serum cryptococcal antigen (sCRAG) titers in patients with AIDS-related cryptococcal disease.

Authors:  J A Aberg; J Watson; M Segal; L W Chang
Journal:  HIV Clin Trials       Date:  2000 Jul-Aug

2.  Impact of HIV infection on meningitis in Harare, Zimbabwe: a prospective study of 406 predominantly adult patients.

Authors:  J G Hakim; I T Gangaidzo; R S Heyderman; J Mielke; E Mushangi; A Taziwa; V J Robertson; P Musvaire; P R Mason
Journal:  AIDS       Date:  2000-07-07       Impact factor: 4.177

3.  Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial.

Authors:  Annemarie E Brouwer; Adul Rajanuwong; Wirongrong Chierakul; George E Griffin; Robert A Larsen; Nicholas J White; Thomas S Harrison
Journal:  Lancet       Date:  2004-05-29       Impact factor: 79.321

Review 4.  HIV-associated cryptococcal meningitis.

Authors:  Joseph N Jarvis; Thomas S Harrison
Journal:  AIDS       Date:  2007-10-18       Impact factor: 4.177

5.  IFN-gamma at the site of infection determines rate of clearance of infection in cryptococcal meningitis.

Authors:  Asna A Siddiqui; Annemarie E Brouwer; Vannaporn Wuthiekanun; Shabbar Jaffar; Robin Shattock; Diane Irving; Joanna Sheldon; Wirongrong Chierakul; Sharon Peacock; Nicholas Day; Nicholas J White; Thomas S Harrison
Journal:  J Immunol       Date:  2005-02-01       Impact factor: 5.422

6.  Role of capsule and interleukin-6 in long-term immune control of Cryptococcus neoformans infection by specifically activated human peripheral blood mononuclear cells.

Authors:  Asna A Siddiqui; Robin J Shattock; Thomas S Harrison
Journal:  Infect Immun       Date:  2006-09       Impact factor: 3.441

7.  Validation of a published case definition for tuberculosis-associated immune reconstitution inflammatory syndrome.

Authors:  Lewis J Haddow; Mahomed-Yunus S Moosa; Philippa J Easterbrook
Journal:  AIDS       Date:  2010-01-02       Impact factor: 4.177

8.  Proportions of circulating T cells with a regulatory cell phenotype increase with HIV-associated immune activation and remain high on antiretroviral therapy.

Authors:  Andrew Lim; Dino Tan; Patricia Price; Adeeba Kamarulzaman; Hong-Yien Tan; Ian James; Martyn A French
Journal:  AIDS       Date:  2007-07-31       Impact factor: 4.177

9.  Causes of death in a rural, population-based human immunodeficiency virus type 1 (HIV-1) natural history cohort in Uganda.

Authors:  M Okongo; D Morgan; B Mayanja; A Ross; J Whitworth
Journal:  Int J Epidemiol       Date:  1998-08       Impact factor: 7.196

10.  Independent association between rate of clearance of infection and clinical outcome of HIV-associated cryptococcal meningitis: analysis of a combined cohort of 262 patients.

Authors:  Tihana Bicanic; Conrad Muzoora; Annemarie E Brouwer; Graeme Meintjes; Nicky Longley; Kabanda Taseera; Kevin Rebe; Angela Loyse; Joseph Jarvis; Linda-Gail Bekker; Robin Wood; Direk Limmathurotsakul; Wirongrong Chierakul; Kasia Stepniewska; Nicholas J White; Shabbar Jaffar; Thomas S Harrison
Journal:  Clin Infect Dis       Date:  2009-09-01       Impact factor: 9.079

View more
  99 in total

Review 1.  Management of the immune reconstitution inflammatory syndrome.

Authors:  Graeme Meintjes; James Scriven; Suzaan Marais
Journal:  Curr HIV/AIDS Rep       Date:  2012-09       Impact factor: 5.071

Review 2.  Update on opportunistic infections in the era of effective antiretroviral therapy.

Authors:  Brian C Zanoni; Rajesh T Gandhi
Journal:  Infect Dis Clin North Am       Date:  2014-09       Impact factor: 5.982

3.  Cryptococcal Meningitis: Diagnosis and Management Update.

Authors:  Mahsa Abassi; David R Boulware; Joshua Rhein
Journal:  Curr Trop Med Rep       Date:  2015-06-01

4.  Immune reconstitution disorders in patients with HIV infection: from pathogenesis to prevention and treatment.

Authors:  C C Chang; V Sheikh; I Sereti; M A French
Journal:  Curr HIV/AIDS Rep       Date:  2014-09       Impact factor: 5.071

5.  Fungal infections of the central nervous system.

Authors:  Claire S Jacobs; Mark R Etherton; Jennifer L Lyons
Journal:  Curr Infect Dis Rep       Date:  2014-12       Impact factor: 3.725

6.  Late onset of cryptococcal cervical lymphadenitis following immune reconstitution inflammatory syndrome in a patient with AIDS.

Authors:  Meenakshi Sethupathi; Kathir Yoganathan
Journal:  BMJ Case Rep       Date:  2015-01-06

7.  Significantly improved analytical sensitivity of lateral flow immunoassays by using thermal contrast.

Authors:  Zhenpeng Qin; Warren C W Chan; David R Boulware; Taner Akkin; Elissa K Butler; John C Bischof
Journal:  Angew Chem Int Ed Engl       Date:  2012-03-23       Impact factor: 15.336

Review 8.  Neurologic Complications of Human Immunodeficiency Virus Infection.

Authors:  Deanna Saylor
Journal:  Continuum (Minneap Minn)       Date:  2018-10

Review 9.  The immunopathogenesis of cryptococcal immune reconstitution inflammatory syndrome: understanding a conundrum.

Authors:  David B Meya; Yukari C Manabe; David R Boulware; Edward N Janoff
Journal:  Curr Opin Infect Dis       Date:  2016-02       Impact factor: 4.915

10.  Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis.

Authors:  David R Boulware; David B Meya; Conrad Muzoora; Melissa A Rolfes; Katherine Huppler Hullsiek; Abdu Musubire; Kabanda Taseera; Henry W Nabeta; Charlotte Schutz; Darlisha A Williams; Radha Rajasingham; Joshua Rhein; Friedrich Thienemann; Melanie W Lo; Kirsten Nielsen; Tracy L Bergemann; Andrew Kambugu; Yukari C Manabe; Edward N Janoff; Paul R Bohjanen; Graeme Meintjes
Journal:  N Engl J Med       Date:  2014-06-26       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.